XPAM Stock Overview
Amundi Index Solutions - Amundi MSCI EM Asia is an exchange traded fund launched and managed by Amundi Asset Management.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Amundi Index Solutions - Amundi MSCI EM Asia Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£35.15 |
| 52 Week High | UK£35.28 |
| 52 Week Low | UK£29.97 |
| Beta | 0 |
| 1 Month Change | 0.50% |
| 3 Month Change | 9.26% |
| 1 Year Change | 14.16% |
| 3 Year Change | -4.24% |
| 5 Year Change | 29.04% |
| Change since IPO | 21.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| XPAM | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | 1.6% | 4.4% | 1.8% |
| 1Y | 14.2% | 25.4% | 4.2% |
Return vs Industry: XPAM underperformed the German Capital Markets industry which returned 23.3% over the past year.
Return vs Market: XPAM exceeded the German Market which returned 2.8% over the past year.
Price Volatility
| XPAM volatility | |
|---|---|
| XPAM Average Weekly Movement | 2.9% |
| Capital Markets Industry Average Movement | 4.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: XPAM has not had significant price volatility in the past 3 months.
Volatility Over Time: XPAM's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | n/a | n/a |
Amundi Index Solutions - Amundi MSCI EM Asia is an exchange traded fund launched and managed by Amundi Asset Management. The fund invests in the public equity markets of the emerging countries in Asia. It uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors.
Amundi Index Solutions - Amundi MSCI EM Asia Fundamentals Summary
| XPAM fundamental statistics | |
|---|---|
| Market cap | €553.61m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs XPAM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XPAM income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did XPAM perform over the long term?
See historical performance and comparison